Hong Kong
Cancer drug developer seeks $7b in secondary Hong Kong listing
Cancer drug developer seeks $7b in secondary Hong Kong listing
BeiGene is offering 65.6 million shares at $94.9 to $111.6 apiece.
Citibank Hong Kong boosts API ecosystem with three new partnerships
Watsons, EGL Tours and Fortress will integrate Citi Pay with Points API into their platforms.
Over 60 applicants scramble for a Hong Kong virtual banking license
This includes Standard Chartered Bank and online loan platform WeLab.
Exchange Fund income plunges 80% to $23.9b in H1 amidst trade worries
The fund’s total assets hit $4.1t.
Nearly half of students expect parents to pitch in for home purchases
However, this may still be insufficient to cover skyrocketing home costs.
Private flat supply pegged at 93,000 for the next four years
This is 3,000 less than the previous estimate.
Landing International Development's $1.5b casino project greenlit
It will be built in Entertainment City, Manila.
Investment returns in Hong Kong offices plunge to thirty year low
It’s the only major market where returns are lower than a 10-year US Treasury Bond.
No such thing as home sweet home: Half of residents uninterested in buying property
Nearly 70% believe that home prices will climb in the next year.
Naspers eyes Hong Kong listing for e-commerce arm
It houses assets like OLX.
Trade jitters dampen export growth to 3.3% in June
This comes from 12.9% expansion in May.
Hong Kong Exchange delays WVR plans
The bourse isn't pushing through with a planned stakeholder consultation.
Hong Kong clinics brace for heated Chinese infant vaccine demand
The moves come after a Mainland biotech firm falsified data for its shots.
Trade tensions fail to rattle Hong Kong SMEs in Q3
SME sentiment tracker remained at 49.7.
Fanling site sold for $732.9m
It was awarded to Macro Topper Limited.
SFC slaps HSBC Broking Securities with $9.6m fine
The firm failed to conduct due diligence in a bond sale between 2015 to 2016.
The search is on for Hong Kong's leading technology innovators
Nomination is open until November 9.
Read Here
Advertise
Sign Up
Commentary
Hong Kong: At the forefront of digitalisation and evolving international disputes
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Capital repatriation isn't a retreat — it’s Hong Kong’s regulatory graduation
Hong Kong should build the Asia–Latin America investment corridor